Salivary gland carcinoma in children and adolescents: The EXPeRT/PARTNER diagnosis and treatment recommendations
Surun A, Schneider DT, Ferrari A, Stachowicz-Stencel T, Rascon J, Synakiewicz A, Agaimy A, Martinova K, Kachanov D, Roganovic J, Bien E, Bisogno G, Brecht IB, Kolb F, Thariat J, Moya-Plana A, Orbach D (2021)
Publication Type: Journal article
Publication year: 2021
Journal
Book Volume: 68
DOI: 10.1002/pbc.29058
Abstract
Salivary gland carcinomas (SGCs) are rare during childhood and adolescence. Consequently, no standardized recommendations for the diagnosis and therapeutic management of pediatric SGC are available, and pediatric oncologists and surgeons generally follow adult guidelines. Complete surgical resection with adequate margins constitutes the cornerstone of treatment. However, the indications and modalities of adjuvant therapy remain controversial and may be challenging in view of the potential long-term toxicities in the pediatric population. This paper presents the consensus recommendations for the diagnosis and treatment of children and adolescents with SGCs, established by the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) within the EU-funded PARTNER project (Paediatric Rare Tumours Network - European Registry).
Authors with CRIS profile
Involved external institutions
PSL Research University / Université de recherche Paris Sciences et Lettres
France (FR)
Klinikum Dortmund
Germany (DE)
Fondazione IRCCS: Istituto Nazionale dei Tumori
Italy (IT)
Medical University Gdansk / Gdański Uniwersytet Medyczny
Poland (PL)
Vilnius University Hospital Santaros Klinikos / Vilniaus Universiteto ligoninė Santaros klinikos
Lithuania (LT)
Saints Cyril and Methodius University of Skopje / Универзитет „Св. Кирил и Методиј“ во Скопје
Republic of North Macedonia (MK)
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology / Национальный медицинский исследовательский центр детской гематологии, онкологии и иммунологии имени Дмитрия Рогачева
Russian Federation (RU)
Clinical Hospital Center Rijeka / Klinički bolnički centar Rijeka
Croatia (HR)
Azienda Ospedale Università Padova / University Hospital of Padova
Italy (IT)
Eberhard Karls Universität Tübingen
Germany (DE)
University of California, San Diego
United States (USA) (US)
Center François Baclesse
France (FR)
Institut Gustave-Roussy
France (FR)
France (FR)
Klinikum Dortmund
Germany (DE)
Fondazione IRCCS: Istituto Nazionale dei Tumori
Italy (IT)
Medical University Gdansk / Gdański Uniwersytet Medyczny
Poland (PL)
Vilnius University Hospital Santaros Klinikos / Vilniaus Universiteto ligoninė Santaros klinikos
Lithuania (LT)
Saints Cyril and Methodius University of Skopje / Универзитет „Св. Кирил и Методиј“ во Скопје
Republic of North Macedonia (MK)
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology / Национальный медицинский исследовательский центр детской гематологии, онкологии и иммунологии имени Дмитрия Рогачева
Russian Federation (RU)
Clinical Hospital Center Rijeka / Klinički bolnički centar Rijeka
Croatia (HR)
Azienda Ospedale Università Padova / University Hospital of Padova
Italy (IT)
Eberhard Karls Universität Tübingen
Germany (DE)
University of California, San Diego
United States (USA) (US)
Center François Baclesse
France (FR)
Institut Gustave-Roussy
France (FR)
How to cite
APA:
Surun, A., Schneider, D.T., Ferrari, A., Stachowicz-Stencel, T., Rascon, J., Synakiewicz, A.,... Orbach, D. (2021). Salivary gland carcinoma in children and adolescents: The EXPeRT/PARTNER diagnosis and treatment recommendations. Pediatric Blood & Cancer, 68. https://doi.org/10.1002/pbc.29058
MLA:
Surun, Aurore, et al. "Salivary gland carcinoma in children and adolescents: The EXPeRT/PARTNER diagnosis and treatment recommendations." Pediatric Blood & Cancer 68 (2021).
BibTeX: Download